CollPlant (CLGN) shareholders back both August EGM items
Rhea-AI Filing Summary
CollPlant Biotechnologies Ltd. (CLGN) reports that it held an Extraordinary General Meeting of Shareholders on August 18, 2026. Shareholders approved both proposals presented at the meeting, each receiving the required majority as outlined in the previously distributed meeting notice.
The report is also incorporated by reference into the company’s existing Form S-8 and Form F-3 registration statements, meaning the meeting outcome and related disclosures become part of those registration frameworks.
Positive
- None.
Negative
- None.
Key Figures
Meeting date: August 18, 2026
Number of proposals approved: 2
Notice date: July 28, 2026
3 metrics
Meeting date
August 18, 2026
Date of Extraordinary General Meeting of Shareholders
Number of proposals approved
2
Proposals approved at the Extraordinary General Meeting of Shareholders
Notice date
July 28, 2026
Date of Notice of Extraordinary General Meeting of Shareholders referenced in the report
Key Terms
Foreign Private Issuer, Form 6-K, Extraordinary General Meeting of Shareholders, incorporated by reference
4 terms
Foreign Private Issuer regulatory
"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
Form 6-K regulatory
"Form 6-K REPORT OF FOREIGN PRIVATE ISSUER"
A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.
incorporated by reference regulatory
"This Form 6-K is hereby incorporated by reference into the registrant’s"
FAQ
What did CollPlant Biotechnologies Ltd (CLGN) announce in its August 2026 Form 6-K?
CollPlant Biotechnologies Ltd announced that its Extraordinary General Meeting of Shareholders on August 18, 2026 approved both proposals presented. The company also stated this report is incorporated by reference into its existing Form S-8 and Form F-3 registration statements.
Were the proposals at CollPlant (CLGN)'s August 18, 2026 Extraordinary General Meeting approved?
Yes, shareholders approved both proposals presented at the Extraordinary General Meeting on August 18, 2026. Each proposal received the majority required for its approval, as described in the company’s July 28, 2026 Notice of Extraordinary General Meeting of Shareholders.
How does this CollPlant (CLGN) Form 6-K affect its existing registration statements?
The report is incorporated by reference into CollPlant’s registration statements on Form S-8 (multiple file numbers) and Form F-3. This means the information in this report becomes part of those effective registration documents for securities law purposes.
Where can investors find details of the proposals approved at CollPlant (CLGN)'s meeting?
Details of the two approved proposals are in the Notice of Extraordinary General Meeting of Shareholders dated July 28, 2026. That notice was attached as Exhibit 99.1 to a prior Form 6-K furnished to the U.S. Securities and Exchange Commission on the same date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
